Cite
Liquid biopsy of cerebrospinal fluid for MYD88 L265P mutation is useful for diagnosis of central nervous system lymphoma
MLA
Yoshiaki Shiokawa, et al. “Liquid Biopsy of Cerebrospinal Fluid for MYD88 L265P Mutation Is Useful for Diagnosis of Central Nervous System Lymphoma.” Cancer Science, vol. 112, Sept. 2021, pp. 4702–10. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8eccdcd79128d845057f8a29c2d0f81c&authtype=sso&custid=ns315887.
APA
Yoshiaki Shiokawa, Takaki Omura, Saki Shimizu, Koichi Ichimura, Motoo Nagane, Akihide Kondo, Kuniaki Saito, Yoshitaka Narita, Yuko Matushita, Keiichi Kobayashi, Nobuyoshi Sasaki, Yoshiko Nakano, & Yuki Yamagishi. (2021). Liquid biopsy of cerebrospinal fluid for MYD88 L265P mutation is useful for diagnosis of central nervous system lymphoma. Cancer Science, 112, 4702–4710.
Chicago
Yoshiaki Shiokawa, Takaki Omura, Saki Shimizu, Koichi Ichimura, Motoo Nagane, Akihide Kondo, Kuniaki Saito, et al. 2021. “Liquid Biopsy of Cerebrospinal Fluid for MYD88 L265P Mutation Is Useful for Diagnosis of Central Nervous System Lymphoma.” Cancer Science 112 (September): 4702–10. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8eccdcd79128d845057f8a29c2d0f81c&authtype=sso&custid=ns315887.